BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11197248)

  • 1. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study.
    Kim HJ; Kim BH; Han YS; Yang I; Kim KJ; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
    Am J Gastroenterol; 2001 Jan; 96(1):165-9. PubMed ID: 11197248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism].
    Lian XL; Bai Y; Dai WX; Jin ZM; Zeng ZP; Guo ZS
    Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):442-6. PubMed ID: 15312442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Propylthiouracil-induced overt hepatic injury in patients with hyperthyroidism].
    Lian XL; Bai Y; Dai WX; Guo ZS; Li W; Lu L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):172-7. PubMed ID: 15171556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in liver biochemical tests at diagnosis and after propylthiouracil therapy for hyperthyroidism.
    Gürlek A; Cobankara V; Bayraktar M
    Mater Med Pol; 1996; 28(3):103-6. PubMed ID: 9167420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Asymptomatic hepatitis induced by propylthiouracil].
    De Castro JJ; Nobre EL; Garcia e Costa J; Galvão-Teles A
    Acta Med Port; 2001; 14(5-6):523-7. PubMed ID: 11878166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study.
    Liaw YF; Huang MJ; Fan KD; Li KL; Wu SS; Chen TJ
    Ann Intern Med; 1993 Mar; 118(6):424-8. PubMed ID: 8439116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver tests in hyperthyroidism: effect of antithyroid therapy.
    Gürlek A; Cobankara V; Bayraktar M
    J Clin Gastroenterol; 1997 Apr; 24(3):180-3. PubMed ID: 9179740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propylthiouracil-induced hepatic damage.
    Ozenírler S; Tuncer C; Boztepe U; Akyol G; Alkim H; Cakir N; Kandílć U
    Ann Pharmacother; 1996 Sep; 30(9):960-3. PubMed ID: 8876856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.
    Wang MT; Lee WJ; Huang TY; Chu CL; Hsieh CH
    Br J Clin Pharmacol; 2014 Sep; 78(3):619-29. PubMed ID: 25279406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putting propylthiouracil in perspective.
    Cooper DS; Rivkees SA
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1881-2. PubMed ID: 19401361
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.
    Yang J; Li LF; Xu Q; Zhang J; Weng WW; Zhu YJ; Dong MJ
    Thyroid; 2015 Mar; 25(3):278-83. PubMed ID: 25384184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hyperthyroidism and propylthiouracil treatment on liver biochemical tests.
    Aydemir S; Bayraktaroglu T; Demircan N; Sert M; Açikgoz S; Tekin IO; Ustundag Y
    Int J Clin Pract; 2005 Nov; 59(11):1304-8. PubMed ID: 16236085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gone (from the Physicians' desk reference) but not forgotten: propylthiouracil-associated hepatic failure: a call for liver test monitoring.
    Primeggia J; Lewis JH
    J Natl Med Assoc; 2010 Jun; 102(6):531-4. PubMed ID: 20575220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute cholestatic hepatitis induced by propylthiouracil. Case report].
    Parolin MB; Lopes RW; Telles JE; Ioshii SO; Hajar N
    Arq Gastroenterol; 2000; 37(2):129-32. PubMed ID: 11144016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics of propylthiouracil (PTU) induced antineutrophil cytoplasmic antibodies positive cases; analysis of a case of PTU-induced ANCA positive patients with hyperthyroidism].
    Li MT; Zeng XJ; Fang WG; Li H; Li XM; Feng K; Li YZ; Zeng XF; Zhang FC; Tang FL
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2082-5. PubMed ID: 15730621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study.
    Huang MJ; Li KL; Wei JS; Wu SS; Fan KD; Liaw YF
    Am J Gastroenterol; 1994 Jul; 89(7):1071-6. PubMed ID: 7912472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with carbimazole of a hyperthyroid pregnancy with hepatic impairment after propylthiouracil administration: a case report.
    Kontoleon P; Ilias I; Koutras DA; Kontogiannis D; Papapetrou PD
    Clin Exp Obstet Gynecol; 2002; 29(4):304-5. PubMed ID: 12635752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propylthiouracil-induced severe hepatitis: a case report and review of the literature.
    Ichiki Y; Akahoshi M; Yamashita N; Morita C; Maruyama T; Horiuchi T; Hayashida K; Ishibashi H; Niho Y
    J Gastroenterol; 1998 Oct; 33(5):747-50. PubMed ID: 9773944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The propylthiouracil dilemma.
    Glinoer D; Cooper DS
    Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):402-7. PubMed ID: 22820213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propylthiouracil-induced nonspecific interstitial pneumonia.
    Lee JY; Chung JH; Lee YJ; Park SS; Kim SY; Koo HK; Lee JH; Lee CT; Yoon HI
    Chest; 2011 Mar; 139(3):687-690. PubMed ID: 21362656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.